ACTIDIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actidil, and what generic alternatives are available?
Actidil is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in ACTIDIL is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.
Summary for ACTIDIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 4,744 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACTIDIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ACTIDIL
US Patents and Regulatory Information for ACTIDIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | ACTIDIL | triprolidine hydrochloride | SYRUP;ORAL | 011496-002 | Jul 1, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | ACTIDIL | triprolidine hydrochloride | TABLET;ORAL | 011110-002 | Jul 1, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |